 |
Circle Pharma
Last updated: October 06, 2024
David Earp, president and CEO
USA | Funding: $207.5M (+)
Website: https://circlepharma.com
Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides with applications in Rb-dysregulated cancers and cyclin-E-dependent malignancies
Website: https://circlepharma.com
Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides with applications in Rb-dysregulated cancers and cyclin-E-dependent malignancies
